Northwell Health offers drug that aims to reduce transmission of HIV/AIDS
Northwell Health in Manhasset is offering an FDA-approved drug called Yeztugo, which is taken twice a year.
•
Jul 18, 2025, 2:21 AM
•
Updated 5 hr ago
Share:
More Stories
2:03
Partly sunny skies, warm temperatures for Friday in Brooklyn
4h ago1:37
Community weighs in on Kent Avenue efficiency and safety plan for bike lane
4h ago1:40
Giglio lift draws thousands to Williamsburg in centuries-old tradition
4h ago1:35
Kingsbridge residents take part in nationwide 'Good Trouble Lives On' rally
4h ago2:35
HEAT ALERT: Dangerous heat eventually eases; humidity shoved south
4h ago2:05
South Plainfield Elks Lodge seeks community’s help following flood damage
5h ago2:03
Partly sunny skies, warm temperatures for Friday in Brooklyn
4h ago1:37
Community weighs in on Kent Avenue efficiency and safety plan for bike lane
4h ago1:40
Giglio lift draws thousands to Williamsburg in centuries-old tradition
4h ago1:35
Kingsbridge residents take part in nationwide 'Good Trouble Lives On' rally
4h ago2:35
HEAT ALERT: Dangerous heat eventually eases; humidity shoved south
4h ago2:05
South Plainfield Elks Lodge seeks community’s help following flood damage
5h agoHIV-AIDS has affected Americans for decades, but now a new drug will help prevent cases of the disease.
Northwell Health in Manhasset is offering an FDA-approved drug called Yeztugo, which is taken twice a year.
One Northwell Health patient who has lived with AIDS since 2010 says she wishes the medication had come sooner.
“I think others should consider it, so you can protect yourself from having it. Therefore, we have a better life ahead of us without complications of our health,” says the patient.
The drug is a preventative in order to reduce the risk of contracting the disease